Medical Equipment

Corvia Medical Completes Randomization In REDUCE LAP-HF II Pivotal Trial And Gains FDA Authorization To Provide Continued Access For The Corvia Atrial Shunt

Large randomized, sham-controlled trial evaluates interatrial shunting in a heart failure population currently without effective treatment TEWKSBURY, Mass., Nov. 17, 2020 /PRNewswire/ -- Corvia Medical, Inc., a company dedicated to transforming the treatment of heart failure (HF), today announce...

2020-11-17 19:00 1008

Late-Breaking Study Results of the Supreme HT™ Healing-Targeted DES Demonstrated Equivalent Outcomes with Exceptional Safety

TIANJIN, China, Nov. 17, 2020 /PRNewswire/ -- SINOMED® today announced that Prof.Alexandra Lansky from the Yale School of Medicine, USA, presented data from its first inter-continental PIONEER III study comparing the safety and efficacy of the Supreme HT (Healing-Targeted) Drug-Eluting Stent, t...

2020-11-17 18:49 2133

Big Bets on Wuhan: United Imaging "at Full Steam" to Support Health Industry Upgrade

WUHAN, China, Nov. 16, 2020 /PRNewswire/ -- Wuhan, the epicenter of the COVID-19 outbreak, now stages an epic comeback as the second World Health Expo 2020 opens here onNov. 11, 2020. Industry thought leaders, including Margaret Chan Fung Fu-chun, former Director-General of WHO, Nobel laureates i...

2020-11-17 09:12 1577

Sofwave receives CE Medical Mark and additional key Regulatory Clearances for its Revolutionary Skin Tightening and Wrinkle Reduction Device

YOQNEAM, Israel, Nov. 17, 2020 /PRNewswire/ -- Sofwave Medical, the emerging leader of energy-based non-invasive aesthetic medical devices, announced today that it has secured CE Mark (Conformité Européenne) for its next-generation Sofwave system which was approved for use for the treatment of fi...

2020-11-17 01:00 1760

Positive Results from RhoVac's Clinical Phase I/II Study published in Journal of ImmunoTherapy of Cancer

STOCKHOLM, Nov. 13, 2020 /PRNewswire/ -- RhoVac announces today, November 13, 2020, that the results of its clinical phase I/II study have been published in the Journal for ImmunoTherapy of Cancer (JITC). The scientifically reviewed article reports that the treatment with RhoVac's drug candidate ...

2020-11-13 17:53 2412

iONEBIO Inc. Deployment of FICS (Fast Infection Control System) at the International Airport of Paraguay

* iONEBIO iLAMP Novel-CoV19 Detection Kit is a high-speed laboratory assay intended as a groundbreaking aid in the diagnosis of SARS-CoV-2 infection. * This technologically advanced solution was developed in an attempt to serve as the gold standard in high-throughput high-accuracy testing, wit...

2020-11-13 16:29 1924

iONEBIO Inc. Deployment of FICS (Fast Infection Control System) at the International Airport of Paraguay

* iONEBIO iLAMP Novel-CoV19 Detection Kit is a high-speed laboratory assay intended as a groundbreaking aid in the diagnosis of SARS-CoV-2 infection. * This technologically advanced solution was developed in an attempt to serve as the gold standard in high-throughput high-accuracy testing, wit...

2020-11-13 15:18 1884

Ascensia Diabetes Care Showcases The Crucial Support Nurses Provide People With Diabetes To Celebrate World Diabetes Day 2020

BASEL, Switzerland, Nov. 13, 2020 /PRNewswire/ -- Ascensia Diabetes Care, a leading global diabetes care company and maker of the CONTOUR® range of blood glucose monitoring systems, is tomorrow celebrating the crucial role that nurses play in helping people manage their diabetes, as part of World...

2020-11-13 14:00 3096

Integrating Fitbit Wearable Devices into Diabetes Care Leads to Significant Improvements in Blood Glucose and HbA1C, Finds Health2Sync Clinical Study in Taiwan

* Wearing Fitbit devices with Health2Sync glucose control app clinically proven to help both users and healthcare providers to control and better manage the symptoms of Type 2 diabetes * Results from the study in Taiwan revealed an improvement in patients' health conditions, with participants...

2020-11-13 11:07 2315

Integrating Fitbit Wearable Devices into Diabetes Care Leads to Significant Improvements in Blood Glucose and HbA1C, Finds Health2Sync Clinical Study in Taiwan

* Wearing Fitbit devices with Health2Sync glucose control app clinically proven to help both users and healthcare providers to control and better manage the symptoms of Type 2 diabetes * Results from the study in Taiwan revealed an improvement in patients' health conditions, with participants...

2020-11-13 10:34 1939

Integrating Fitbit Wearable Devices into Diabetes Care Leads to Significant Improvements in Blood Glucose and HbA1C, Finds Health2Sync Clinical Study in Taiwan

* Wearing Fitbit devices with Health2Sync glucose control app clinically proven to help both users and healthcare providers to control and better manage the symptoms of Type 2 diabetes * Results from the study in Taiwan revealed an improvement in patients' health conditions, with participants...

2020-11-13 10:32 2102

Integrating Fitbit Wearable Devices into Diabetes Care Leads to Significant Improvements in Blood Glucose and HbA1C, Finds Health2Sync Clinical Study in Taiwan

* Wearing Fitbit devices with Health2Sync glucose control app clinically proven to help both users and healthcare providers to control and better manage the symptoms of Type 2 diabetes * Results from the study in Taiwan revealed an improvement in patients' health conditions, with participants...

2020-11-13 10:29 2061

Integrating Fitbit Wearable Devices into Diabetes Care Leads to Significant Improvements in Blood Glucose and HbA1C, Finds Health2Sync Clinical Study in Taiwan

* Wearing Fitbit devices with Health2Sync glucose control app clinically proven to help both users and healthcare providers to control and better manage the symptoms of Type 2 diabetes * Results from the study in Taiwan revealed an improvement in patients' health conditions, with participants...

2020-11-13 10:26 2242

Green Shield Introduces New Face Masks for Beards

WESTMINSTER, Calif., Nov. 12, 2020 /PRNewswire/ -- Green Shield has introduced a new face mask for bearded consumers. While Green Shield's brand vision is that everyone has the right to protect themselves; and for millions of men who want to have a beard and also wear a protective face mask that ...

2020-11-12 19:19 1042

Casio to Exhibit Medical Camera for Global Market at virtual.MEDICA 2020

TOKYO, Nov. 12, 2020 /PRNewswire/ -- Casio Computer Co., Ltd. announced on October 22, 2020 that it will unveil its medical camera to the global market for the first time at virtual. MEDICA 2020, one of the world's largest medical device exhibitions, which will be held online this year fromNovemb...

2020-11-12 17:12 1901

B. Braun Thailand wins 'Best Company to Work for in Asia' Award

BANGKOK, Nov. 12, 2020 /PRNewswire/ -- B. Braun Thailand won the coveted 'Best Companies to Work for inAsia 2020 Award' by HR Asia on 16th October 2020. B. Braun Thailand wins ‘Best Company to Work for in Asia’ Award   B. B...

2020-11-12 09:16 2176

Intelligent temperature detection device produced by ICETECH is favored by global market, helping pandemic prevention

BEIJING, Nov. 11, 2020 /PRNewswire/ -- As the epidemic continues, countries keep improving prevention measures and policies. As more peoplereturn to work and production is encouraged by the government,  a kind of smart device which could quickly and correctly perform temperature measurement and f...

2020-11-12 08:00 1191

Spine Innovations gains its independence, aims for massive growth in sales of its ESP® Disc Replacements in Spine

HEIMSBRUNN, France, Nov. 11, 2020 /PRNewswire/ -- Following the acquisition of its parent company FH Ortho by Olympus Corporation, Spine Innovations has become a fully independent company — and dedicated itself to worldwide sales deployment of its ESP® disc replacements. This development demonstr...

2020-11-12 03:45 1351

cPass(TM) SARS-CoV-2 Neutralization Antibody kit is the first EUA authorized test that detects neutralizing antibodies within one hour

SINGAPORE, Nov. 11, 2020 /PRNewswire/ -- Following GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK)'s cPass™ SARS-CoV-2 Neutralization Antibody Detection Kit has received provisional authorization by Health Science Authority (HSA)Singapore on 8th May 2020, CE-IVD marking in Europ...

2020-11-11 17:30 6818

cPass(TM) SARS-CoV-2 Neutralization Antibody kit is the first EUA authorized test that detects neutralizing antibodies within one hour

SINGAPORE, Nov. 11, 2020 /PRNewswire/ -- Following GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK)'s cPass™ SARS-CoV-2 Neutralization Antibody Detection Kit has received provisional authorization by Health Science Authority (HSA)Singapore on 8th May 2020, CE-IVD marking in Europ...

2020-11-11 16:09 4652
1 ... 117118119120121122123 ... 147